40 results
8-K
EX-99.1
RNXT
RenovoRx Inc
18 Apr 24
Other Events
4:15pm
to transforming the lives of patients by delivering innovative solutions to change the current paradigm of cancer care. RenovoGem is currently under investigation
8-K
EX-99.1
RNXT
RenovoRx Inc
15 Apr 24
Unregistered Sales of Equity Securities
9:00am
to transforming the lives of patients by delivering innovative solutions to change the current paradigm of cancer care. RenovoGem is currently under
8-K
EX-99.1
RNXT
RenovoRx Inc
9 Apr 24
RenovoRx Announces $11.1 Million At Market Private Placement
4:15pm
to transforming the lives of patients by delivering innovative solutions to change the current paradigm of cancer care. RenovoGem is currently under
8-K
EX-99.1
6jxwdvsy4 gw32v6
29 Jan 24
RenovoRx Closes $6.1 Million Private Placement
9:06am
8-K
EX-99.1
280u80en2rwhv4ell
14 Nov 23
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
12:00am
8-K
EX-99.1
a2rk9p2eggd3kdzzlqb
17 Aug 23
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
8:30am
424B3
rb3n1yzf0hr24 4rtq
19 May 23
Prospectus supplement
5:07pm
8-K
EX-99.1
rtq19 3xghpfrw96tu
15 May 23
RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
8:30am
8-K
EX-99.1
xqftnnfglti54jgfv4
27 Apr 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
s7gtgeis
3 Apr 23
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:45pm
424B5
nli7 f3qbgwv9sh5hf4b
3 Apr 23
Prospectus supplement for primary offering
9:00am
8-K
EX-99.1
tswyi3zv736j00gd1a
14 Nov 22
RenovoRx Reports Third Quarter 2022 Financial Results
8:45am